Equities

Aesthetic Medical International Holdings Group Ltd

Aesthetic Medical International Holdings Group Ltd

Actions
  • Price (USD)0.2502
  • Today's Change0.00 / 0.00%
  • Shares traded688.00
  • 1 Year change-62.09%
  • Beta-0.0672
Data delayed at least 15 minutes, as of Nov 22 2024 16:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments621239
Total Receivables, Net343544
Total Inventory162831
Prepaid expenses------
Other current assets, total--2.630
Total current assets11278114
Property, plant & equipment, net327344359
Goodwill, net333333
Intangibles, net3.884.274.06
Long term investments01.164.90
Note receivable - long term------
Other long term assets------
Total assets561546577
LIABILITIES
Accounts payable424731
Accrued expenses354271
Notes payable/short-term debt20650
Current portion long-term debt/capital leases109200184
Other current liabilities, total205190255
Total current liabilities411544542
Total long term debt116128221
Total debt245393406
Deferred income tax0.0100.29
Minority interest(15)(12)(30)
Other liabilities, total----0
Total liabilities512660734
SHAREHOLDERS EQUITY
Common stock0.980.630.47
Additional paid-in capital------
Retained earnings (accumulated deficit)(870)(840)(792)
Treasury stock - common(2.02)(2.02)(2.02)
Unrealized gain (loss)------
Other equity, total920728636
Total equity49(114)(157)
Total liabilities & shareholders' equity561546577
Total common shares outstanding1438865
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.